CNA' s fourth quarter core income of $317 million is down 7% compared to the prior year quarter of $342 million but continues to reflect strong underwriting and investment results. Full year 2025 core income of $1,342 million is a best on record leading to a core return on equity of 10.6%. This result reflects a P&C underwriting gain of $551 million and record high net investment income of $2,557 million, which is 2% higher than 2024. Our P&C expense ratio was 30.1% for the fourth quarter and 29.7% for the full year. The expense ratio for the fourth quarter includes a half point non-recurring technology charge while both periods benefited from higher net earned premiums. While there is always a certain amount of variability quarter to quarter, we currently believe an expense ratio close to 30.0% is a reasonable run-rate heading into 2026. The P&C net prior period development impact on the combined ratio was neutral in the current quarter. In the Specialty segment, prior period development was $27 million unfavorable primarily from other professional and management liability. In the Commercial segment, prior period development was negligible overall with favorable development in workers' compensation, offset by unfavorable development in commercial auto and general liability. For the International segment, prior period development was $25 million favorable primarily from property and marine. The paid to incurred ratio for our P&C segments was 0.88 for the fourth quarter. We do see some fluctuations quarter to quarter, so we tend to take a longer view of this metric. The paid to incurred ratio was 0.82 for the full year of 2025 and has been quite stable between 0.80 and 0.83 for each of the last four full years. Our Corporate segment produced a core loss of $103 million in the fourth quarter compared to a $91 million loss in the fourth quarter of 2024. The loss this quarter includes the results of our annual fourth quarter asbestos and environmental pollution (A&EP) reserve review resulting in additional cessions of $185 million to the $4 billion loss portfolio transfer (LPT), which was incepted in 2010. This strengthening of reserves is associated with higher defense and indemnity costs on existing claims. This review resulted in a non economic, after-tax charge of $67 million as compared to a $35 million charge in the prior year quarter. Following this review, our cumulative incurred losses of $3.9 billion dollars remain within the $4 billion LPT limit while cumulative paid losses are $2.8 billion. You will recall from previous years' reviews that under retroactive reinsurance accounting, there is a timing difference with respect to recognizing the benefit of the cover relative to incurred losses as we can only do so in proportion to the paid losses recovered under the treaty. As such, holding all else constant, the loss recognized today will be recaptured over time through the amortization of the deferred accounting gain as paid losses ultimately catch up with the losses incurred. As of year-end 2025, we have $470 million of deferred gain that will be recaptured over time. Finally, there was no prior period development associated with legacy mass tort abuse reserves in the fourth quarter, compared to a $17 million after-tax charge in the prior year quarter. As we have noted in prior calls, we perform our annual review of A&EP reserves during the fourth quarter, and we evaluate all other corporate segment reserves primarily in the second quarter. For the Life & Group segment, we had a core loss of $29 million in the fourth quarter as compared to a core loss of $18 million in the prior year quarter, reflecting unfavorable persistency experience. Life & Group full year core loss of $44 million is a larger loss than the 2024 core loss of $23 million due to lower investment income. The full year 2025 underwriting result is about flat with 2024, with both full year results being broadly in-line with expectations. Finally, inforce management actions including the pursuit of rate and policy buyouts are ongoing. Since we launched our buyout program in 2020, we have bought out approximately 12,000 policies releasing nearly $400 million of statutory reserves. Turning to investments, net investment income was $653 million in the fourth quarter compared with $644 million in the prior year quarter, an increase of 1%. The increase was driven by our fixed income and other investments, partially offset by lower, albeit solid, returns in our limited partnership and common stock portfolios. Fixed income and other investments generated $576 million of income, up 5% compared to the prior year quarter. Our A-rated fixed income portfolio continues to provide consistent contributions to core income, which have been steadily increasing because of favorable reinvestment rates and strong cash flow from operations. The effective income yield of our consolidated fixed income portfolio was 4.9% in the fourth quarter, up from 4.8% in the prior year quarter. Reinvestment rates continue to be above our P&C portfolio effective income yield of 4.4% and are fairly in line with our Life & Group portfolio effective income yield of 5.7%. Our limited partnership and common stock portfolio returned a $77 million gain, or 2.7%, in the current quarter compared to a $94 million gain, or 3.5%, in the prior year quarter. Total net investment income was a best on record of $2,557 million for the full year 2025 compared with $2,497 million in 2024, an increase of 2%. Similar to the quarterly results, the increase was driven by our fixed income and other investments, partially offset by lower, but still strong, returns in our limited partnership and common stock portfolios. Fixed income and other investments generated $2,255 million of income for the year, up 4% compared to the prior year. Limited partnerships and common stocks generated $302 million of income representing a 11.1% return compared to $320 million of income representing a return of 13.3% in the prior year. Looking ahead to 2026, based on the current interest rate environment we expect income from fixed income and other investments to be about $575 million in the first quarter, which is about flat compared to the fourth quarter of 2025 given what we expect to be limited reinvestment activity. For the full year, we expect income from fixed income and other investments to be about $2,325 million, or a 3% increase as compared to the full year 2025. At quarter end, our balance sheet continues to be very solid with stockholders' equity excluding accumulated other comprehensive income (AOCI) of $12.7 billion, or $46.99 per share, an increase of 10% from year-end 2024 adjusting for dividends. Stockholders' equity including AOCI was $11.6 billion or $42.93 per share. With the decline in interest rates in 2025, the net unrealized investment loss in our fixed income portfolio decreased to $1.2 billion as of year-end, roughly half the level at year-end 2024. Finally, we ended 2025 with statutory capital and surplus in the combined Continental Casualty Companies of $11.6 billion, which is a record high and is up from $11.2 billion at the end of 2024. We continue to maintain a conservative capital structure with a low leverage ratio and a well-balanced debt maturity schedule. We are especially pleased with the fourth quarter action taken by AM Best who upgraded CNA' s financial strength rating to A+ with a comparable upgrade to CNA' s debt ratings - both with stable outlooks. We view AM Best' s actions as recognition of the significant progress we have made in the performance of the business in recent years. Operating cash flow for the year was strong once again at $2.5 billion, which reflects continued strong underwriting and investment results. Turning to taxes, the effective tax rate on core income for the fourth quarter was 20.4% and reflects a benefit for tax-exempt investment income, somewhat offset by state income taxes. The full year 2025 effective tax rate on core income was 21.1%, which is consistent with a 21% effective tax rate we expect for 2026, although there will be a certain amount of variability quarter-to-quarter. Finally, given the company' s strong underwriting and investment performance, we are pleased to announce we are increasing our regular quarterly dividend by 4% from $0.46 per share to $0.48 per share. In addition, we are declaring a special dividend of $2.00 per share - both dividends will be paid on March 12, 2026, to shareholders of record on February 23, 2026. Using this past Friday' s closing price, CNA shares have a very attractive dividend yield of approximately 8%, inclusive of the $2.00 special dividend.